AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26258821 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (placebo treatment)
Number of subjects: 16
Study 23885649 — intervention group
Group type: EXPERIMENTAL
Intervention: Early surgery (<48 h) for patients on antiplatelet therapy
Number of subjects: 175
Study 23885649 — intervention group
Group type: COMPARATOR
Intervention: Delayed surgery (>5 days) for patients on antiplatelet therapy
Number of subjects: 175
Study 23885649 — intervention group
Group type: EXPERIMENTAL
Intervention: Early surgery (<48 h) for patients not on antiplatelet therapy
Number of subjects: 175
Study 23885649 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients on antiplatelet therapy
Number of subjects: 175
Study 23885649 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall mortality analysis
Number of subjects: 175
Study 23885649 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfusion requirements
Number of subjects: 175
Study 22160369 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training program (3 times a week, cycling at 75% maximal heart rate) for 3 months
Number of subjects: 17
Study 22160369 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (control group)
Number of subjects: 17
Study 19394017 — intervention group
Group type: EXPERIMENTAL
Intervention: Falling Efficacy Scale (FES)
Number of subjects: 168
Study 19394017 — intervention group
Group type: EXPERIMENTAL
Intervention: Activities-Specific Balance Confidence Scale (ABC)
Number of subjects: 168
Study 19394017 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric Fear of Falling Measurement (GFFM)
Number of subjects: 168
Study 19394017 — intervention group
Group type: EXPERIMENTAL
Intervention: FES vs. ABC
Number of subjects: 168
Study 19394017 — intervention group
Group type: EXPERIMENTAL
Intervention: FES vs. GFFM
Number of subjects: 168
Study 19394017 — intervention group
Group type: EXPERIMENTAL
Intervention: ABC vs. GFFM
Number of subjects: 168
Study 16507182 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsalva manoeuvre during venepuncture
Number of subjects: 110
Study 16507182 — intervention group
Group type: COMPARATOR
Intervention: No Valsalva manoeuvre during venepuncture
Number of subjects: 110
Study 15093913 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy
Number of subjects: 46
Study 11700577 — intervention group
Group type: EXPERIMENTAL
Intervention: Tafenoquine 400 mg for 3 days followed by placebo weekly
Number of subjects: 249
Study 11700577 — intervention group
Group type: EXPERIMENTAL
Intervention: Tafenoquine 200 mg for 3 days followed by 200 mg per week
Number of subjects: 249
Study 11700577 — intervention group
Group type: EXPERIMENTAL
Intervention: Tafenoquine 400 mg for 3 days followed by 400 mg per week
Number of subjects: 249
Study 11700577 — intervention group
Group type: COMPARATOR
Intervention: Placebo throughout
Number of subjects: 249
Study 9142510 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-TNF alpha monoclonal antibodies
Number of subjects: 0
Study 9142510 — intervention group
Group type: COMPARATOR
Intervention: Elderly with high NK activity
Number of subjects: 0
Study 9142510 — intervention group
Group type: COMPARATOR
Intervention: Elderly with low NK activity
Number of subjects: 0
Study 9142510 — intervention group
Group type: COMPARATOR
Intervention: Young individuals
Number of subjects: 0
Study 7944932 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human interferon gamma, 100 micrograms, administered subcutaneously once daily for 21 days (or until patient discharge if prior to 21 days)
Number of subjects: 416
Study 7944932 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 416
Study 2895461 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg loprazolam
Number of subjects: 12
Study 2895461 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 31872398 — intervention group
Group type: EXPERIMENTAL
Intervention: Recreational swimming program
Number of subjects: 40
Study 31872398 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 28406803 — intervention group
Group type: EXPERIMENTAL
Intervention: Mind-Body Bridging (MBB)
Number of subjects: 60
Study 28406803 — intervention group
Group type: COMPARATOR
Intervention: Sleep Education Control (SED)
Number of subjects: 60
Study 26159167 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon dilatation
Number of subjects: 0
Study 26159167 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser myotomy
Number of subjects: 0
Study 23420574 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 ml beer (4.7% vol)
Number of subjects: 12
Study 23420574 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 ml red wine (13.7% vol)
Number of subjects: 12
Study 23420574 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 ml whisky (43.5% vol)
Number of subjects: 12
Study 23420574 — intervention group
Group type: COMPARATOR
Intervention: Matching volumes of control fluids
Number of subjects: 12
Study 23420574 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcoholic beverages (beer, red wine)
Number of subjects: 12
Study 23420574 — intervention group
Group type: EXPERIMENTAL
Intervention: Whisky and high proof ethanol solution
Number of subjects: 12
Study 23420574 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcoholic beverages
Number of subjects: 12
Study 17161050 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 36
Study 17161050 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 36
Study 12731402 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetotherapy (2.9 microT; frequency‐‐40 Hz; square wave; Magnetronic MF‐‐10 apparatus) applied for 20 min to the lumbar area, repeated 15 times
Number of subjects: 26
Study 12731402 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetostimulation (Viofor JPS system; M2P2 program; induction‐‐25‐80 microT; frequency‐‐200 Hz, complex saw‐like shape) applied for 12 min daily, repeated 15 times
Number of subjects: 26
Study 12731402 — intervention group
Group type: COMPARATOR
Intervention: Comparison of magnetotherapy and magnetostimulation
Number of subjects: 26
Study 10431577 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy followed by hematopoietic stem cell transplant
Number of subjects: 0
Study 10431577 — intervention group
Group type: COMPARATOR
Intervention: Conventional chemotherapy
Number of subjects: 0
Study 7742127 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast-enhanced MR imaging using high dose (0.3 mmol/kg b.w.) Gadodiamide injection
Number of subjects: 16
Study 7742127 — intervention group
Group type: COMPARATOR
Intervention: Contrast-enhanced MR imaging using standard dose (0.1 mmol/kg b.w.) Gadodiamide injection
Number of subjects: 16
Study 7742127 — intervention group
Group type: COMPARATOR
Intervention: Contrast-enhanced CT
Number of subjects: 16
Study 7742127 — intervention group
Group type: COMPARATOR
Intervention: Non-contrast-enhanced MR imaging
Number of subjects: 16
Study 1952841 — intervention group
Group type: EXPERIMENTAL
Intervention: Rimantadine (10 days treatment)
Number of subjects: 36
Study 1952841 — intervention group
Group type: EXPERIMENTAL
Intervention: Rimantadine (5 days treatment)
Number of subjects: 36
Study 1952841 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 6452790 — intervention group
Group type: EXPERIMENTAL
Intervention: Zimelidine (selective serotonin‐uptake inhibitor)
Number of subjects: 8
Study 6452790 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramine (selective norepinephrine uptake inhibitor)
Number of subjects: 8
Study 6452790 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Zimelidine and Desipramine
Number of subjects: 8
Study 6452790 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 8
Study 29546525 — intervention group
Group type: EXPERIMENTAL
Intervention: Swallowing exercise education program (SEEP)
Number of subjects: 76
Study 29546525 — intervention group
Group type: COMPARATOR
Intervention: Normal care (Control)
Number of subjects: 76
Study 29546525 — intervention group
Group type: COMPARATOR
Intervention: Both groups (Experimental and Control)
Number of subjects: 76
Study 27995517 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 cm group
Number of subjects: 60
Study 27995517 — intervention group
Group type: COMPARATOR
Intervention: 8 cm group
Number of subjects: 60
Study 27995517 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study 25873255 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended Brief Intervention (EBI)
Number of subjects: 50
Study 22959094 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 15 mg
Number of subjects: 10
Study 22959094 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabeprazole 10 mg
Number of subjects: 10
Study 21982652 — intervention group
Group type: EXPERIMENTAL
Intervention: Alogliptin
Number of subjects: 5400
Study 21982652 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5400
Study 18494625 — intervention group
Group type: EXPERIMENTAL
Intervention: ORC/collagen matrix
Number of subjects: 27
Study 18494625 — intervention group
Group type: COMPARATOR
Intervention: Control (hydrocolloid dressing)
Number of subjects: 27
Study 15722807 — intervention group
Group type: EXPERIMENTAL
Intervention: Observer NRS during stretching procedure
Number of subjects: 19
Study 15722807 — intervention group
Group type: EXPERIMENTAL
Intervention: NCCPC-PV during stretching procedure
Number of subjects: 19
Study 15722807 — intervention group
Group type: EXPERIMENTAL
Intervention: CFCS scores across time segments
Number of subjects: 19
Study 12947063 — intervention group
Group type: EXPERIMENTAL
Intervention: ACNU plus VM26 (90 mg/m2 IV on day 1 and 60 mg/m2 IV on days 1 to 3)
Number of subjects: 362
Study 12947063 — intervention group
Group type: EXPERIMENTAL
Intervention: ACNU plus Ara‐C (90 mg/m2 IV on day 1 and 120 mg/m2 IV on days 1 to 3)
Number of subjects: 362
Study 10674508 — intervention group
Group type: EXPERIMENTAL
Intervention: rapacuronium 1 mg x kg(‐1)
Number of subjects: 103
Study 10674508 — intervention group
Group type: EXPERIMENTAL
Intervention: rapacuronium 2 mg x kg(‐1)
Number of subjects: 103
Study 10674508 — intervention group
Group type: EXPERIMENTAL
Intervention: rapacuronium 3 mg x kg(‐1)
Number of subjects: 103
Study 10674508 — intervention group
Group type: COMPARATOR
Intervention: mivacurium 0.2 mg x kg(‐1)
Number of subjects: 103
Study 8554083 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose levodopa and carbidopa
Number of subjects: 20
Study 8554083 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher, conventional dose of levodopa and carbidopa
Number of subjects: 20
Study 8554083 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 1899080 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nitroglycerin (10 mg, releasing 6 to 7 mg in 12 hr)
Number of subjects: 14
Study 1899080 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 6285445 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (20 mg)
Number of subjects: 16
Study 6285445 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (20 mg, 3 times daily)
Number of subjects: 16
Study 6285445 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (10 mg, 3 times daily)
Number of subjects: 16
Study 6285445 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 30845731 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined supplementation with glycine (3.0 g) and tryptophan (0.2 g)
Number of subjects: 0
Study 30845731 — intervention group
Group type: COMPARATOR
Intervention: Placebo powder
Number of subjects: 0
Study 29069016 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotip application (-10°C for 15 seconds)
Number of subjects: 30
Study 29069016 — intervention group
Group type: COMPARATOR
Intervention: Control (no cryotip application)
Number of subjects: 30
Study 27266506 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular point acupressure (APP) treatment using vaccaria seeds on the large intestine point (CO7)
Number of subjects: 0
Study 27266506 — intervention group
Group type: COMPARATOR
Intervention: APP sham stimulation
Number of subjects: 0
Study 24864635 — intervention group
Group type: EXPERIMENTAL
Intervention: Tubularised incised plate urethroplasty
Number of subjects: 60
Study 24864635 — intervention group
Group type: COMPARATOR
Intervention: Onlay island flap repair
Number of subjects: 60
Study 21883559 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium hydroxide paste with polyethylene glycol
Number of subjects: 32
Study 21883559 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium hydroxide paste with chlorhexidine
Number of subjects: 32
Study 21883559 — intervention group
Group type: COMPARATOR
Intervention: Biomechanical preparation
Number of subjects: 32
Study 18992952 — intervention group
Group type: EXPERIMENTAL
Intervention: RT+CON (radiotherapy with carbogen and nicotinamide)
Number of subjects: 165
Study 18992952 — intervention group
Group type: COMPARATOR
Intervention: RT (radiotherapy alone)
Number of subjects: 165
Study 17592648 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Food group (TFG)
Number of subjects: 96
Study 17592648 — intervention group
Group type: EXPERIMENTAL
Intervention: Meal Replacement Group (MRG)
Number of subjects: 96
Study 15279340 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural anesthesia (Group E)
Number of subjects: 114
Study 15279340 — intervention group
Group type: COMPARATOR
Intervention: Spinal anesthesia (Group S)
Number of subjects: 114
Study 12503840 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol (0.7 g/kg)
Number of subjects: 20
Study 12503840 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 9802364 — intervention group
Group type: EXPERIMENTAL
Intervention: Fel d 1 peptides (high dose, 750 micro(g))
Number of subjects: 31
Study 9802364 — intervention group
Group type: EXPERIMENTAL
Intervention: Fel d 1 peptides (medium dose, 75 micro(g))
Number of subjects: 31
Study 9802364 — intervention group
Group type: EXPERIMENTAL
Intervention: Fel d 1 peptides (low dose, 7.5 micro(g))
Number of subjects: 31
Study 9802364 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 7636411 — intervention group
Group type: EXPERIMENTAL
Intervention: Method 2
Number of subjects: 60
Study 7636411 — intervention group
Group type: COMPARATOR
Intervention: Method 1
Number of subjects: 60
Study 2367154 — intervention group
Group type: EXPERIMENTAL
Intervention: Williamson‐Kligmann technique (on the epidermis of the forearm)
Number of subjects: 10
Study 2367154 — intervention group
Group type: COMPARATOR
Intervention: Bag of Gaschen technique (on the hands)
Number of subjects: 10
Study 138573 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin
Number of subjects: 0
Study 138573 — intervention group
Group type: COMPARATOR
Intervention: Tetracycline
Number of subjects: 0
Study 30694609 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral care with sterile normal saline
Number of subjects: 92
Study 30694609 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 92
Study 28617377 — intervention group
Group type: EXPERIMENTAL
Intervention: Laennec infusions (10 intravenous infusions, 4 ml each, 2 times/week for 5 weeks)
Number of subjects: 38
Study 28617377 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 38
Study 26491117 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (9 mg elemental zinc daily for 4 weeks)
Number of subjects: 147
Study 26491117 — intervention group
Group type: COMPARATOR
Intervention: Placebo (identical tablet for 4 weeks)
Number of subjects: 147
Study 24036613 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative periarticular infiltration with ropivacaine, clonidine, morphine, epinephrine and corticosteroids
Number of subjects: 63
Study 24036613 — intervention group
Group type: COMPARATOR
Intervention: Patient-controlled analgesia (PCA) with morphine
Number of subjects: 63
Study 24036613 — intervention group
Group type: COMPARATOR
Intervention: Continuous epidural infusion with ropivacaine
Number of subjects: 63
Study 21763247 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard endotracheal intubation (ETI)
Number of subjects: 204
Study 21763247 — intervention group
Group type: COMPARATOR
Intervention: Supraglottic airway device (King LTS‐D)
Number of subjects: 204
Study 18952450 — intervention group
Group type: EXPERIMENTAL
Intervention: Left atrial plus cavotricuspid isthmus ablation (left atrial group)
Number of subjects: 299
Study 18952450 — intervention group
Group type: COMPARATOR
Intervention: Biatrial ablation (biatrial group)
Number of subjects: 299
Study 18952450 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall patients
Number of subjects: 299
Study 16530831 — intervention group
Group type: EXPERIMENTAL
Intervention: varR1-CHOP (1 cycle of rituximab + 6 cycles of CHOP)
Number of subjects: 16
Study 16530831 — intervention group
Group type: EXPERIMENTAL
Intervention: varR3-CHOP (3 cycles of rituximab + 6 cycles of CHOP)
Number of subjects: 16
Study 16530831 — intervention group
Group type: EXPERIMENTAL
Intervention: varR6-CHOP (6 cycles of rituximab + 6 cycles of CHOP)
Number of subjects: 16
Study 15312558 — intervention group
Group type: EXPERIMENTAL
Intervention: Oseltamivir (75 mg, twice daily for 5 days)
Number of subjects: 108
Study 15312558 — intervention group
Group type: COMPARATOR
Intervention: Control (symptom relief medicine only)
Number of subjects: 108
Study 11224816 — intervention group
Group type: EXPERIMENTAL
Intervention: BSA only (SA25)
Number of subjects: 35
Study 11224816 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of BSA and resistance exercise (SAR)
Number of subjects: 35
Study 11224816 — intervention group
Group type: EXPERIMENTAL
Intervention: BSA only (SA40)
Number of subjects: 35
Study 11224816 — intervention group
Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 35
Study 9085965 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure at the P.6 (Nei‐Guan) point
Number of subjects: 200
Study 9085965 — intervention group
Group type: COMPARATOR
Intervention: Control group with inappropriate placement of acupressure bands
Number of subjects: 200
Study 8338516 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptives
Number of subjects: 17032
Study 8338516 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrauterine devices
Number of subjects: 17032
Study 8338516 — intervention group
Group type: COMPARATOR
Intervention: Diaphragm
Number of subjects: 17032
Study 3464622 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized regimen based on DDFM (T group)
Number of subjects: 90
Study 3464622 — intervention group
Group type: COMPARATOR
Intervention: 3-month recalls (C group)
Number of subjects: 90
Study 3464622 — intervention group
Group type: EXPERIMENTAL
Intervention: DDFM of subgingival bacterial morphotypes
Number of subjects: 90
Study 31220326 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity, multicomponent childhood overweight/obesity intervention
Number of subjects: 963
Study 31220326 — intervention group
Group type: COMPARATOR
Intervention: Families informed about the program
Number of subjects: 963
Study 30550321 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitor + Accept
Number of subjects: 0
Study 30550321 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitor Only
Number of subjects: 0
Study 30550321 — intervention group
Group type: COMPARATOR
Intervention: No treatment control
Number of subjects: 0
Study 30550321 — intervention group
Group type: COMPARATOR
Intervention: Active control training
Number of subjects: 0
Study 27353149 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimonthly, discount, mobile fresh fruit and vegetable markets combined with a nutrition education intervention (two F&V campaigns, newsletters, DVDs, and cooking demonstrations) for 12 months.
Number of subjects: 15
Study 27353149 — intervention group
Group type: COMPARATOR
Intervention: Physical activity and stress reduction interventions (Control group).
Number of subjects: 15
Study 24926950 — intervention group
Group type: EXPERIMENTAL
Intervention: Leuprolide acetate depot 11.25 mg
Number of subjects: 72
Study 24926950 — intervention group
Group type: EXPERIMENTAL
Intervention: Leuprolide acetate depot 30 mg
Number of subjects: 72
Study 24926950 — intervention group
Group type: EXPERIMENTAL
Intervention: Leuprolide acetate depot (both doses)
Number of subjects: 72
Study 22897185 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer‐CDSMP (Cardiac‐Diabetes Self‐Management Program)
Number of subjects: 30
Study 22897185 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 20631016 — intervention group
Group type: EXPERIMENTAL
Intervention: Good glycemic control (HbA(1c) <6.5%)
Number of subjects: 273
Study 20631016 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor glycemic control (HbA(1c) >6.5%)
Number of subjects: 273
Study 20631016 — intervention group
Group type: EXPERIMENTAL
Intervention: Decrease in insulin sensitivity (1 mg x kg(‐1) x min(‐1))
Number of subjects: 273
Study 18768000 — intervention group
Group type: COMPARATOR
Intervention: Halogen lamp (550 mW/cm² for 20 seconds)
Number of subjects: 24
Study 18768000 — intervention group
Group type: EXPERIMENTAL
Intervention: LED (550 mW/cm² for 25 seconds)
Number of subjects: 24
Study 18768000 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% hydrogen peroxide
Number of subjects: 24
Study 18768000 — intervention group
Group type: EXPERIMENTAL
Intervention: 16% carbamide peroxide
Number of subjects: 24
Study 18768000 — intervention group
Group type: COMPARATOR
Intervention: Control (no bleaching)
Number of subjects: 24
Study 16006212 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer education (n = 204)
Number of subjects: 204
Study 16006212 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-session lecture (n = 74)
Number of subjects: 204
Study 16006212 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control (n = 109)
Number of subjects: 204
Study 12235693 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic therapy for 14 days
Number of subjects: 0
Study 12235693 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 9952142 — intervention group
Group type: EXPERIMENTAL
Intervention: Endotracheal tube
Number of subjects: 52
Study 9952142 — intervention group
Group type: COMPARATOR
Intervention: Laryngeal mask airway
Number of subjects: 52
Study 7591530 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrient supplementation for one year
Number of subjects: 47